AAV2-antiVEGFscFv gene therapy for retinal neovascularization

Retinal neovascularization (NV) may lead to irreversible vision impairment, the main treatment for which is the inhibition of vascular endothelial growth factor (VEGF). Existing drugs show limited clinical benefits because of their high prices and short half-lives, which increase the financial burde...

Descripción completa

Detalles Bibliográficos
Autores principales: Han, Ni, Xu, Xin, Liu, Ying, Luo, Guangzuo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Gene & Cell Therapy 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10679950/
https://www.ncbi.nlm.nih.gov/pubmed/38027065
http://dx.doi.org/10.1016/j.omtm.2023.101145

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10679950/
https://www.ncbi.nlm.nih.gov/pubmed/38027065
http://dx.doi.org/10.1016/j.omtm.2023.101145

Ejemplares similares